Pharma IQ Glossary: Follow-on Biologics
-
Improving the Security, Quality & Compliance of your Biologic Operation
February 21 by Pharma IQIn the coming years, biologics are expected to make up a greater proportion of revenue growth for pharmaceutical companies, with some figures placing it as high as 60 per cent. The US Food...
FDA to Issue Guidance on the Biosimilar Pathway by End of 2011
May 17 by Pharma IQIt was only matter of time before the United States Food and Drug Administration (FDA) put in place guidance for the marketing of biosimiliars – and it would seem that time is almost upon us. Global...
Navigating the U.S. Department of Transportation’s Regulations for Biologics and Biological Agents
April 20 by Pharma IQPharma IQ chats with Eileen Edmonson, Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, about navigating the U.S. Department of Transportation’s regulations fo...
